Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tessenderlo Group N.V. (TESB.BR)
Brussels, BE
Tessenderlo Group N.V., a global entity established in 1919 and headquartered in Brussels, Belgium, is a subsidiary of Verbrugge NV. The company, which rebranded from Tessenderlo Chemie nv in June 2017, operates across four principal segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power, serving diverse end markets such as agriculture, food, industry, construction, health, and consumer goods. The Agro division is dedicated to the manufacturing, marketing, and distribution of essential crop nutrients, including liquid and potassium sulfate fertilizers sold under brands like Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluPotasse, and K-Leaf. Additionally, it provides crop protection products such as LINEX and VELPAR herbicides, SEVIN insecticide, and SECTAGON fumigant. Through its Bio-Valorization segment, Tessenderlo Group transforms bio-residuals into a range of valuable products like gelatins, collagen peptides, proteins, and fats. These are supplied to various sectors, including food, pharmaceutical, health and nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary markets. The Industrial Solutions arm manufactures and supplies plastic pipe systems and chemicals for water treatment. This segment also encompasses other industrial activities, including the production and sale of mining and industrial auxiliaries, alongside specialized services for treating and disposing of produced and flowback water from oil and gas exploration, and recovering industrial process fluids. Finally, the T-Power segment focuses on energy generation, utilizing a 425 MW combined cycle gas turbine to produce electricity.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.29% | +2.80% | +3.04% | -18.22% | -20.00% | -16.03% | -18.37% | -22.67% | -36.87% | -31.10% | -51.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.4% Q4'25: -2.0% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%-291.4% Q4'25: -351.1% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.8% Q4'25: +1.6% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%-1.7% Q4'25: -7.6% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%-2.6% Q4'25: -22.2% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%-1.4% ★ Q4'25: -2.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.21× Q4'25: 21.66× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2000 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 2 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.77B
est.
|
1.91B
est.
|
1.93B
est: 1.99B (-2.9%)
|
1.97B
est: 2.01B (-1.9%)
|
2.06B
est: 2.12B (-2.7%)
|
2.15B
est: 2.16B (-0.5%)
|
2.24B
est: 2.29B (-2.1%)
|
2.41B
est: 2.44B (-1.5%)
|
2.77B
est: 2.80B (-1.3%)
|
2.09B
est: 2.11B (-0.9%)
|
2.43B
est: 2.43B (+0.1%)
|
2.13B
est: 2.15B (-1.2%)
|
2.13B
est: 2.13B (-0.1%)
|
1.79B
est: 1.84B (-2.6%)
|
1.43B
est: 1.45B (-0.9%)
|
1.59B
est: 1.55B (+2.5%)
|
1.59B
est: 1.59B (-0.1%)
|
1.66B
est: 1.64B (+1.0%)
|
1.62B
est: 1.63B (-0.6%)
|
1.74B
est: 1.75B (-0.3%)
|
1.74B
est: 1.75B (-0.7%)
|
2.08B
est: 1.92B (+8.5%)
|
2.59B
est: 2.53B (+2.4%)
|
2.93B
est: 2.69B (+8.8%)
|
2.65B
est: 2.66B (-0.5%)
|
2.76B
est: 2.77B (-0.3%)
|
2.84B
2.76B – 2.92B
+2.5% YoY
|
2.94B
2.87B – 3.09B
+3.5% YoY
|
3.05B
3.04B – 3.05B
+3.7% YoY
|
2.99B
2.91B – 3.11B
-1.9% YoY
|
| EBITDA |
236.53M
est.
|
247.99M
est.
|
240.78M
est: 210.53M (+14.4%)
|
66.60M
est: 228.98M (-70.9%)
|
203.40M
est: 220.78M (-7.9%)
|
192.70M
est: 188.09M (+2.5%)
|
128.30M
est: 177.01M (-27.5%)
|
328.60M
est: 117.77M (+179.0%)
|
376.70M
est: 333.53M (+12.9%)
|
-6.40M
est: 255.06M (-102.5%)
|
219.20M
est: -40.66M (+639.0%)
|
203.70M
est: 118.85M (+71.4%)
|
-82.70M
est: 159.14M (-152.0%)
|
44.90M
est: -72.61M (+161.8%)
|
133.20M
est: 19.55M (+581.4%)
|
176.40M
est: 141.63M (+24.5%)
|
195.80M
est: 203.62M (-3.8%)
|
186.20M
est: 215.33M (-13.5%)
|
204.10M
est: 49.39M (+313.2%)
|
266.30M
est: 221.14M (+20.4%)
|
313.30M
est: 248.36M (+26.1%)
|
355.70M
est: 255.30M (+39.3%)
|
428.10M
est: 260.90M (+64.1%)
|
327.50M
est: 326.86M (+0.2%)
|
264.00M
est: 327.58M (-19.4%)
|
164.30M
est: 336.60M (-51.2%)
|
344.86M
335.73M – 354.54M
+2.5% YoY
|
356.86M
348.40M – 374.78M
+3.5% YoY
|
370.22M
369.42M – 371.01M
+3.7% YoY
|
363.10M
353.99M – 377.39M
-1.9% YoY
|
| EBIT |
120.43M
est.
|
144.24M
est.
|
104.81M
est: 112.32M (-6.7%)
|
-68.03M
est: 114.59M (-159.4%)
|
86.70M
est: 95.88M (-9.6%)
|
68.10M
est: 70.95M (-4.0%)
|
6.70M
est: 62.64M (-89.3%)
|
199.70M
est: -4.92M (+4,162.3%)
|
231.90M
est: 213.11M (+8.8%)
|
-142.90M
est: 160.65M (-188.9%)
|
89.00M
est: -173.68M (+151.2%)
|
107.00M
est: 50.91M (+110.2%)
|
-164.80M
est: 104.64M (-257.5%)
|
-25.40M
est: -140.13M (+81.9%)
|
65.90M
est: -14.74M (+547.1%)
|
103.50M
est: 55.31M (+87.1%)
|
123.20M
est: 79.25M (+55.5%)
|
115.30M
est: 124.17M (-7.1%)
|
128.10M
est: 108.01M (+18.6%)
|
134.10M
est: 119.53M (+12.2%)
|
183.60M
est: 122.84M (+49.5%)
|
225.80M
est: 126.27M (+78.8%)
|
293.40M
est: 129.04M (+127.4%)
|
126.00M
est: 145.54M (-13.4%)
|
59.50M
est: 145.86M (-59.2%)
|
-45.90M
est: 149.87M (-130.6%)
|
153.55M
149.48M – 157.86M
+2.5% YoY
|
158.90M
155.12M – 166.87M
+3.5% YoY
|
164.84M
164.49M – 165.19M
+3.7% YoY
|
161.67M
157.62M – 168.04M
-1.9% YoY
|
| Net Income |
77.07M
est.
|
97.60M
est.
|
75.17M
est: 67.81M (+10.9%)
|
43.44M
est: 71.28M (-39.1%)
|
53.60M
est: 45.89M (+16.8%)
|
34.20M
est: 43.63M (-21.6%)
|
-24.30M
est: 37.14M (-165.4%)
|
128.70M
est: -25.97M (+595.6%)
|
140.40M
est: 146.58M (-4.2%)
|
-166.70M
est: 106.37M (-256.7%)
|
20.30M
est: -191.83M (+110.6%)
|
-95.60M
est: 18.36M (-620.7%)
|
-198.70M
est: -94.45M (-110.4%)
|
-64.00M
est: -170.66M (+62.5%)
|
53.70M
est: -50.44M (+206.5%)
|
84.50M
est: 58.01M (+45.7%)
|
98.80M
est: 86.85M (+13.8%)
|
25.60M
est: 103.98M (-75.4%)
|
91.70M
est: 24.94M (+267.7%)
|
96.10M
est: 99.55M (-3.5%)
|
99.10M
est: 95.66M (+3.6%)
|
187.80M
est: 98.34M (+91.0%)
|
226.90M
est: 143.70M (+57.9%)
|
109.50M
est: 89.50M (+22.3%)
|
42.70M
est: 61.18M (-30.2%)
|
-81.10M
est: 74.02M (-209.6%)
|
82.84M
78.45M – 87.23M
+11.9% YoY
|
88.34M
79.07M – 97.62M
+6.6% YoY
|
103.90M
80.61M – 120.63M
+17.6% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
333.22M
est.
|
346.56M
est.
|
366.53M
est: 360.67M (+1.6%)
|
370.07M
est: 366.78M (+0.9%)
|
119.90M
est: 390.29M (-69.3%)
|
113.40M
est: 394.52M (-71.3%)
|
116.60M
est: 364.92M (-68.0%)
|
367.80M
est: 371.90M (-1.1%)
|
333.40M
est: 418.25M (-20.3%)
|
323.30M
est: 252.41M (+28.1%)
|
346.50M
est: 371.38M (-6.7%)
|
320.90M
est: 307.33M (+4.4%)
|
330.00M
est: 317.38M (+4.0%)
|
295.40M
est: 272.08M (+8.6%)
|
243.00M
est: 222.66M (+9.1%)
|
262.60M
est: 248.15M (+5.8%)
|
256.80M
est: 256.96M (-0.1%)
|
278.00M
est: 256.44M (+8.4%)
|
272.10M
est: 256.68M (+6.0%)
|
283.60M
est: 285.08M (-0.5%)
|
276.80M
est: 269.76M (+2.6%)
|
306.70M
est: 277.30M (+10.6%)
|
349.30M
est: 283.38M (+23.3%)
|
406.20M
est: 393.89M (+3.1%)
|
419.60M
est: 394.76M (+6.3%)
|
421.00M
est: 405.63M (+3.8%)
|
415.58M
404.58M – 427.25M
+2.5% YoY
|
430.05M
419.84M – 451.64M
+3.5% YoY
|
446.14M
445.18M – 447.10M
+3.7% YoY
|
437.56M
426.59M – 454.79M
-1.9% YoY
|
| EPS |
3.15
est.
|
2.54
est.
|
2.46
est: 2.56 (-3.9%)
|
1.50
est: 1.51 (-0.6%)
|
185.03
est: 2.22 (+8,224.6%)
|
1.21
est: 1.27 (-4.4%)
|
-0.83
est: 1.70 (-148.9%)
|
4.41
est: 3.60 (+22.5%)
|
4.77
est: 5.80 (-17.8%)
|
-5.48
est: -2.29 (-139.7%)
|
0.66
est: 0.72 (-8.5%)
|
-2.94
est: 2.11 (-239.3%)
|
-6.28
est: 1.21 (-620.8%)
|
-2.02
est: 0.18 (-1,209.7%)
|
1.67
est: 1.32 (+26.9%)
|
1.98
est: 1.80 (+9.8%)
|
2.30
est: 2.08 (+10.8%)
|
0.59
est: 1.33 (-55.7%)
|
2.13
est: 1.74 (+22.6%)
|
2.23
est: 2.06 (+8.5%)
|
2.30
est: 3.08 (-25.3%)
|
4.37
est: 3.70 (+18.0%)
|
5.27
est: 5.23 (+0.8%)
|
1.74
est: 1.44 (+21.2%)
|
0.70
est: 1.00 (-30.0%)
|
-1.34
est: 1.21 (-210.7%)
|
1.37
1.29 – 1.44
+12.9% YoY
|
1.46
1.30 – 1.61
+6.6% YoY
|
1.66
1.33 – 1.99
+13.9% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Belgium ETF EWK | 0.49% | 775.0K | 0.49% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.22% | 204.3K | 0.38% |
| 3 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.22% | 204.3K | 0.38% |
| 4 | WisdomTree International SmallCap Dividend Fund DLS | 0.10% | 1.04M | 0.58% |
| 5 | WisdomTree Dynamic International SmallCap Equity ETF DDLS | 0.10% | 410.3K | 0.48% |
| 6 | UBS MSCI EMU Small Cap UCITS ETF EUR dis UEFD.DE | 0.08% | 577.3K | 0.33% |
| 7 | iShares MSCI EMU Small Cap UCITS ETF CES1.L | 0.08% | 809.0K | 0.58% |
| 8 | Avantis International Small Cap Value ETF AVDV | 0.07% | 12.92M | 0.36% |
| 9 | State Street SPDR MSCI Europe Small Cap Value Weighted UCITS ETF EUR Acc ZPRX.DE | 0.06% | 499.6K | 0.30% |
| 10 | Avantis International Small Cap Equity ETF AVDS | 0.04% | 116.4K | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stefaan Haspeslagh | Executive Chairman | 65.8K | male |
| Luc Tack | Chief Executive Officer & Executive Director | 53.0K | male |
| Anne Mie Van Walleghem | Secretary | — | female |
| John Van Essche | Compliance Officer & Legal Counsel | — | male |
| Miguel De Potter | CFO & Investor Relations | — | male |
| Sandra Hoeylaerts | Chief Transformation Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TESB.BR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
